[ZURICH] Swiss pharmaceuticals giant Novartis said Thursday it had struck a mutual agreement with Aurobindo Pharma to cancel a deal to sell Sandoz to the Indian firm.

[GENEVA] Swiss pharmaceutical company Novartis is preparing to give away 100 doses of the world's most expensive drug, which treats a rare childhood disorder, but its recipient selection process...

SINGAPORE healthtech startup Biofourmis is collaborating with Swiss pharmaceutical giant Novartis to start a digital therapeutics programme for patients with heart failure in South-east Asia, it...

[ZURICH] Novartis has received approval from the US Food and Drug Administration for its Beovu drug to treat a cause of vision loss, the Swiss pharmaceuticals company said on Tuesday.

[ZURICH] Novartis Chief Executive Vas Narasimhan, facing an uproar over data manipulation involving US$2.1 million gene therapy Zolgensma, pledged on Monday to tell regulators quickly if credible...

[BEIJING] China has expanded a pilot drug bulk-buying programme to almost the entire country in an attempt to negotiate lower prices from drug manufacturers, heaping fresh pressure on...

CHEMICALS and biotech company Lonza Group will purchase a sterile drug product fill-and-finish facility in Stein, Switzerland, from Novartis.

[NEW YORK] Sanofi named Novartis AG's Paul Hudson as the French drugmaker's next chief executive officer, replacing Olivier Brandicourt with one of the top managers at its Swiss rival.

[ZURICH] Swiss drugmaker Novartis on Friday won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time...

[BENGALURU] Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Japan-headquartered Takeda Pharmaceutical Company's dry eye drug Xiidra for an upfront payment of US$3.4 billion to...